2008
DOI: 10.1016/j.ijpsycho.2007.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Test–retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

5
72
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 122 publications
(77 citation statements)
references
References 83 publications
5
72
0
Order By: Relevance
“…Although P50 amplitudes were not altered by DAT1 polymorphisms, our preliminary findings indicated that P50 suppression, indexed by dP50, tended to be greater in 9R (vs. 10R) individuals during placebo treatment, and was found to be reduced in this same allele group with nicotine (vs. placebo) administration. The notoriously low reliability of the ratio gating (rP50) index may have contributed to its insensitivity to allele type and nicotine, while the relatively higher reliability of dP50 would have maintained suppressor classification across treatment sessions and provided more stability for detecting acute responsiveness to a test dose of nicotine (Rentzsch et al, 2008).These preliminary findings extend results of previous studies reporting a baselinedependency of pharmacologically altered neural and cognitive activity that has been ascribed to inter-individual quantitative variations in synaptic dopamine. Observations that dopamine agonists either improve or impair brain processes have been accounted for by using the inverted-U principle, that is, agonists might stimulate the dopamine system to 'optimal' or overdosed levels in individuals with low and high baseline dopamine system functioning, respectively (Cools, 2008;Cools and Robbins, 2004).…”
supporting
confidence: 69%
See 2 more Smart Citations
“…Although P50 amplitudes were not altered by DAT1 polymorphisms, our preliminary findings indicated that P50 suppression, indexed by dP50, tended to be greater in 9R (vs. 10R) individuals during placebo treatment, and was found to be reduced in this same allele group with nicotine (vs. placebo) administration. The notoriously low reliability of the ratio gating (rP50) index may have contributed to its insensitivity to allele type and nicotine, while the relatively higher reliability of dP50 would have maintained suppressor classification across treatment sessions and provided more stability for detecting acute responsiveness to a test dose of nicotine (Rentzsch et al, 2008).These preliminary findings extend results of previous studies reporting a baselinedependency of pharmacologically altered neural and cognitive activity that has been ascribed to inter-individual quantitative variations in synaptic dopamine. Observations that dopamine agonists either improve or impair brain processes have been accounted for by using the inverted-U principle, that is, agonists might stimulate the dopamine system to 'optimal' or overdosed levels in individuals with low and high baseline dopamine system functioning, respectively (Cools, 2008;Cools and Robbins, 2004).…”
supporting
confidence: 69%
“…Although P50 amplitudes were not altered by DAT1 polymorphisms, our preliminary findings indicated that P50 suppression, indexed by dP50, tended to be greater in 9R (vs. 10R) individuals during placebo treatment, and was found to be reduced in this same allele group with nicotine (vs. placebo) administration. The notoriously low reliability of the ratio gating (rP50) index may have contributed to its insensitivity to allele type and nicotine, while the relatively higher reliability of dP50 would have maintained suppressor classification across treatment sessions and provided more stability for detecting acute responsiveness to a test dose of nicotine (Rentzsch et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In psychiatry, a number of attempts have been made to develop and determine the feasibility of candidate endophenotypes, but few have met all the criteria listed above. For instance, modern brain imaging tools present problems with retest stability, and the heritability of brain activation (deficits) has only rarely been demonstrated [4,5] . However, modern imaging techniques do provide more insight into pathophysiological mechanisms and thus advance our understanding of the biological underpinnings of psychotic symptoms.…”
mentioning
confidence: 99%
“…Last, and maybe most important, it has been shown that P50 gating has a limited retestreliability. 28 Further supporting this idea, there is a wide range of P50 gating values reported in the literature for both schizophrenia patients and healthy subjects, 29 and many studies failed to find a significantly reduced P50 ratio in schizophrenia patients compared with healthy controls. [30][31][32][33][34][35] Problems with test-retest reliability have been noted frequently, especially with ratio values that introduce a disadvantageous signal-to-noise ratio to both the numerator and the denominator.…”
Section: Discussionmentioning
confidence: 94%